Intramedullary Antibiotic Delivery for Emphysematous Osteomyelitis of the Femur.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 30371923.
- Also identified by DOI 10.3928/01477447-20181023-08.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors present a case of bilateral femoral emphysematous osteomyelitis caused by Escherichia coli in a 60-year-old woman with rheumatoid arthritis who was receiving long-term prednisone therapy. The infection in both femoral shafts was eradicated with surgical debridement, followed by insertion of intramedullary rods composed of culture-specific antibiotic cement into the femoral canals in conjunction with 6 weeks of intravenous antibiotics. The rods were subsequently removed, and no signs of further osteomyelitis were recognized at follow-up. To the authors' knowledge, this is the first case of its kind reported in the orthopedic literature. Emphysematous osteomyelitis, a rare and dangerous entity, can be successfully managed by intramedullary antibiotic delivery in the subacute setting. [Orthopedics. 2019; 42(1):e128-e130.].
Medical subject headings
- Anti-Bacterial Agents
- Bone Cements
- Bone Nails
- Osteomyelitis
Anatomy
- femur